Acasti Pharma (NQ: ACST )
2.760
-0.070
(-2.47%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Acasti Pharma
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2021/08/penny-stocks-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2024/02/medical-biotech-stocks1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/image46.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Recap: Acasti Pharma Q4 Earnings
June 23, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Acasti Pharma's Earnings Outlook
February 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/18/image47_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/vaccine-4892059.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/05/image20.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/10/wall-street-bull.jpg)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
Acasti Pharma Reports Third Quarter 2023 Operational Results
February 14, 2023
From Acasti Pharma, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_108.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
From Acasti Pharma, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image47.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/12/23/image40.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/23/image_7.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
December 19, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/20/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21347.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Monday
November 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30794.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/b388e3c9-06d7-4dfb-9eb8-01bccdc60319/small/acasti-color-high-png.png)
Acasti Pharma Reports Second Quarter 2023 Operational Results
November 14, 2022
From Acasti Pharma, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21251.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
November 11, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.